Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Total 13F shares
-
999,534
-
Share change
-
-123,163
-
Total reported value
-
$872,336
-
Price per share
-
$0.87
-
Number of holders
-
40
-
Value change
-
-$113,469
-
Number of buys
-
12
-
Number of sells
-
14
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q3 2024
As of 30 Sep 2024,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
999,534 shares.
The largest 10 holders included
SEEDS INVESTOR LLC, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, Royal Bank of Canada, COMMONWEALTH EQUITY SERVICES, LLC, CIBC WORLD MARKET INC., GEODE CAPITAL MANAGEMENT, LLC, Long Focus Capital Management, LLC, BANK OF MONTREAL /CAN/, and MORGAN STANLEY.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.